Coverage
-
September 22, 2011
A putative class of investors reached an $18 million settlement with Medicis Pharmaceutical Corp. on Wednesday, putting to bed an Arizona suit that accused the dermatological drugmaker and several executives of overstating profits for more than four years.
1 other articles on this case.
View all »